HDX reveals unique fragment ligands for the vitamin D receptor

https://doi.org/10.1016/j.bmcl.2014.05.070Get rights and content

Abstract

Modulation of the vitamin D receptor (VDR) with a ligand has the potential to be useful for the oral treatment of osteoporosis. One component of our lead generation strategy to identify synthetic ligands for VDR included a fragment based drug design approach. Screening of ligands in a VDR fluorescence polarization assay and a RXR/VDR conformation sensing assay resulted in the identification of multiple fragment hits (lean >0.30). These fragment scaffolds were subsequently evaluated for interaction with the VDR ligand binding domain using hydrogen–deuterium exchange (HDX) mass spectrometry. Significant protection of H/D exchange was observed for some fragments in helixes 3, 7, and 8 of the ligand binding domain, regions which are similar to those seen for the natural hormone VD3. The fragments appear to mimic the A-ring of VD3 thereby providing viable starting points for synthetic expansion.

References and notes (26)

  • K.R. Stayrook et al.

    Vitamin D

  • J. Zhang et al.

    Structure

    (2010)
  • D.S. Mortensen et al.

    Bioorg. Med. Chem. Lett.

    (2001)
  • Y. Demizu et al.

    Bioorg. Med. Chem. Lett.

    (2011)
  • S.W. Englander

    J. Am. Soc. Mass Spectrom.

    (2006)
  • J.B. Bruning et al.

    Structure

    (2007)
  • J. Zhang et al.

    Structure

    (2010)
  • N. Rochel et al.

    Mol. Cell

    (2000)
  • B.D. Pascal et al.

    J. Am. Soc. Mass Spectrom.

    (2009)
  • R.M. Evans

    Science

    (1988)
  • A.L.M. Sutton et al.

    Mol. Endocrinol.

    (2003)
  • R.J. Vieth

    Bone. Miner. Res

    (2007)
  • M. Sanford et al.

    Drugs

    (2011)
  • Cited by (0)

    View full text